The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Expanding Access to Investigational Therapies for HIV Infection and AIDS: March 12-13, 1990 Conference Summary
Lawrence Corey, Professor of Laboratory Medicine, Microbiology, and Medicine, University of Washington
Raphael Dolin, Head, Infectious Diseases Unit, University of Rochester School of Medicine and Dentistry
10:00
Discussion
10:45
The Philosophy of Drug Regulation in the United States: Is It Changing from Beneficence to Patient Autonomy?
Moderator:
Dan Brock, Professor of Philosophy, Brown University
Panelists:
Harold Edgar, Professor of Law, Columbia University School of Law
Bernard Lo, Director, Program in Medical Ethics, University of California
Daniel Wikler, Professor, Department of Philosophy, University of Wisconsin
Carol Levine, Executive Director, Citizens Commission on AIDS
12:00
Discussion
1:45
Issues of Cost and Coverage: How Will the Changes Affect the Drug Industry, Payers, and Patients?
Moderator:
Patrick Gage, Executive Vice President, Genetics Institute, Inc.
Panelists:
Jerome Birnbaum, Executive Vice President for Research, Bristol-Myers Squibb Company
Paul De Stefano, Chief Corporate Counsel, Genentech, Inc.
David Higbee, Branch Chief, Catastrophic Medical Services, Office of Coverage Policy, Health Care Financing Administration
Susan Gleeson, Executive Director, Technology Management, Blue Cross and Blue Shield Association
Steven Peskin, Vice President and Medical Director, CIGNA Healthplan of Texas, Inc.
